Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Phase 1 Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of FF-10101-01 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

NCT03194685 is registered in ClinicalTrials.gov with Fujifilm Pharmaceuticals U.S.A., Inc. as lead sponsor.

NCT NCT03194685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03194685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Phase 1 Study to Assess the Safety, Tolerability, Efficacy, and Pharmacokinetics of FF-10101-01 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia
Lead sponsor
Fujifilm Pharmaceuticals U.S.A., Inc.
Phase
Phase 1
Overall status
Completed
Start date
May 5, 2017
Completion date
July 31, 2021
Enrollment
97 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

aml, adult